Frank G. Ondrey

5.9k total citations
118 papers, 4.3k citations indexed

About

Frank G. Ondrey is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Frank G. Ondrey has authored 118 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 38 papers in Cancer Research and 26 papers in Oncology. Recurrent topics in Frank G. Ondrey's work include NF-κB Signaling Pathways (19 papers), Peroxisome Proliferator-Activated Receptors (15 papers) and Head and Neck Cancer Studies (12 papers). Frank G. Ondrey is often cited by papers focused on NF-κB Signaling Pathways (19 papers), Peroxisome Proliferator-Activated Receptors (15 papers) and Head and Neck Cancer Studies (12 papers). Frank G. Ondrey collaborates with scholars based in United States, China and Japan. Frank G. Ondrey's co-authors include Nelson L. Rhodus, Carter Van Waes, Sandra Myers, Zhong Chen, Bin Cheng, Dianne C. Duffey, Vu N A Ho, George L. Adams, Gang Dong and Beverly R. Wuertz and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Frank G. Ondrey

116 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frank G. Ondrey United States	33	1.7k	1.1k	1.1k	736	669	118	4.3k
Ming-Hsui Tsai Taiwan	30	1.1k 0.6×	610 0.5×	432 0.4×	632 0.9×	292 0.4×	93	2.5k
Liang Zhou China	28	1.7k 1.0×	615 0.6×	821 0.8×	387 0.5×	90 0.1×	166	3.0k
Keiichi Morita Japan	24	1.7k 1.0×	416 0.4×	390 0.4×	126 0.2×	190 0.3×	76	2.8k
Pei‐Yi Chu Taiwan	37	2.6k 1.5×	1.5k 1.3×	1.1k 1.1×	63 0.1×	60 0.1×	210	4.7k
Kirsten H. Limesand United States	27	700 0.4×	279 0.3×	221 0.2×	419 0.6×	72 0.1×	63	2.2k
Fabrice Journé Belgium	35	1.4k 0.8×	1.1k 1.0×	392 0.4×	150 0.2×	24 0.0×	113	3.3k
Qing Wei China	28	2.5k 1.5×	659 0.6×	1.4k 1.3×	32 0.0×	73 0.1×	92	4.1k
Tatsuhiko Miyazaki Japan	26	752 0.4×	633 0.6×	229 0.2×	92 0.1×	31 0.0×	196	2.7k
Mehmet Gündüz Türkiye	28	2.5k 1.5×	1.4k 1.2×	541 0.5×	51 0.1×	27 0.0×	167	4.2k
Xue Gao China	33	2.3k 1.3×	431 0.4×	1.5k 1.4×	16 0.0×	101 0.2×	106	3.8k

Countries citing papers authored by Frank G. Ondrey

Since Specialization

Citations

This map shows the geographic impact of Frank G. Ondrey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank G. Ondrey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank G. Ondrey more than expected).

Fields of papers citing papers by Frank G. Ondrey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank G. Ondrey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank G. Ondrey. The network helps show where Frank G. Ondrey may publish in the future.

Co-authorship network of co-authors of Frank G. Ondrey

This figure shows the co-authorship network connecting the top 25 collaborators of Frank G. Ondrey. A scholar is included among the top collaborators of Frank G. Ondrey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank G. Ondrey. Frank G. Ondrey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wuertz, Beverly R., et al.. (2024). Abstract LB139: Disparities in oral precancerous lesion surveillance in the United States upper Midwest. Cancer Research. 84(7_Supplement). LB139–LB139.

Samuels, Tina L., Beverly R. Wuertz, Davis Seelig, et al.. (2024). Inhaled fosamprenavir for laryngopharyngeal reflux: Toxicology and fluid dynamics modeling. Laryngoscope Investigative Otolaryngology. 9(1). e1219–e1219. 10 indexed citations

Wuertz, Beverly R., et al.. (2023). Metabolic and Metabolomic Effects of Metformin in Murine Model of Pulmonary Adenoma Formation. Nutrition and Cancer. 75(3). 1014–1027. 2 indexed citations

Ondrey, Frank G., et al.. (2022). Medical scribes improve documentation consistency and efficiency in an otolaryngology clinic. American Journal of Otolaryngology. 43(4). 103510–103510. 2 indexed citations

Johnston, Nikki, Tina L. Samuels, Christopher G. Goetz, et al.. (2022). Oral and Inhaled Fosamprenavir Reverses Pepsin‐Induced Damage in a Laryngopharyngeal Reflux Mouse Model. The Laryngoscope. 133(S1). S1–S11. 16 indexed citations

Wuertz, Beverly R., et al.. (2019). Chemoprevention of Lung Carcinogenesis by Dietary Nicotinamide and Inhaled Budesonide. Cancer Prevention Research. 12(2). 69–78. 9 indexed citations

Antonides, Jennifer D., Beverly R. Wuertz, Wendy A. Miller, et al.. (2017). Fixed-Dose Combinations of Pioglitazone and Metformin for Lung Cancer Prevention. Cancer Prevention Research. 10(2). 116–123. 21 indexed citations

Wuertz, Beverly R., et al.. (2017). Abstract 5267: Chemoprevention of lung carcinogenesis by dietary nicotinamide and inhaled budesonide. Cancer Research. 77(13_Supplement). 5267–5267. 1 indexed citations

Wuertz, Beverly R., et al.. (2015). Abstract 914: Pioglitazone and metformin as potential chemopreventative treatments in Fanconi anemia related oral squamous carcinoma. Cancer Research. 75(15_Supplement). 914–914. 2 indexed citations

10.

Unger, Gretchen M., Betsy T. Kren, Vicci L. Korman, et al.. (2014). Mechanism and Efficacy of Sub–50-nm Tenfibgen Nanocapsules for Cancer Cell–Directed Delivery of Anti-CK2 RNAi to Primary and Metastatic Squamous Cell Carcinoma. Molecular Cancer Therapeutics. 13(8). 2018–2029. 25 indexed citations

11.

Sosa, Julie Ann, Rossella Elisei, Barbara Jarząb, et al.. (2013). Randomized Safety and Efficacy Study of Fosbretabulin with Paclitaxel/Carboplatin Against Anaplastic Thyroid Carcinoma. Thyroid. 24(2). 232–240. 116 indexed citations

12.

Caicedo‐Granados, Emiro, Beverly R. Wuertz, & Frank G. Ondrey. (2011). Enforced expression of nuclear factor kappa B in p53 deficient keratinocytes induces cell cycle, angiogenic potential and tumorigenesis. Oral Oncology. 48(4). 303–310. 3 indexed citations

13.

Lin, Jizhen, Zhong Guan, Chuan Wang, et al.. (2009). Inhibitor of Differentiation 1 Contributes to Head and Neck Squamous Cell Carcinoma Survival via the NF-κB/Survivin and Phosphoinositide 3-Kinase/Akt Signaling Pathways. Clinical Cancer Research. 16(1). 77–87. 58 indexed citations

14.

Rhodus, Nelson L., Bin Cheng, Sandra Myers, et al.. (2005). A comparison of the pro-inflammatory, NF-κB-dependent cytokines: TNF-alpha, IL-1-alpha, IL-6, and IL-8 in different oral fluids from oral lichen planus patients. Clinical Immunology. 114(3). 278–283. 137 indexed citations

15.

Lokeh, Adam, Charles I. Benjamin, Peter A. Hilger, et al.. (2000). Contribution of Conventional Axial Computed Tomography (Nonhelical), in Conjunction With Panoramic Tomography (Zonography), in Evaluating Mandibular Fractures. Annals of Plastic Surgery. 45(4). 415–421. 13 indexed citations

16.

Ondrey, Frank G., Andrew J. Griffith, Carter Van Waes, et al.. (2000). Asymptomatic laryngeal malformations are common in patients with Pallister-Hall syndrome. American Journal of Medical Genetics. 94(1). 64–67. 36 indexed citations

17.

Ondrey, Frank G., et al.. (1999). Modulation of Cellular Proliferation and Induction of Apoptosis in a Human Lymphoma Cell Line After Treatment with Selective Lipoxygenase Inhibitors. Advances in experimental medicine and biology. 469. 563–568. 2 indexed citations

18.

Anderson, Kelly, Frank G. Ondrey, & Jennifer Harris. (1999). Do lipoxygenases modulate normal or aberrant lympho-hematopoiesis?. Leukemia Research. 23(1). 51–56. 5 indexed citations

19.

Anderson, Kelly, Thomas M. Seed, Frank G. Ondrey, & Jennifer Harris. (1994). The selective 5-lipoxygenase inhibitor A63162 reduces PC3 proliferation and initiates morphologic changes consistent with secretion.. PubMed. 14(5A). 1951–60. 12 indexed citations

20.

Anderson, K.M., et al.. (1990). Tumor cell mitochondrial matrix/cristae complexes as potential sites for anticancer therapy with polyunsaturated fatty acid analogues. Prostaglandins Leukotrienes and Essential Fatty Acids. 40(2). 137–141. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact